Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancer

Molecular Pharmaceutics

Volumn 11, Issue 2, 2014, Pages 468-476

  Wayua, Charity ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

cholecystokinin 2 receptor; colorectal cancer; fluorescence guided surgery; gastrin receptor; gastrointestinal cancer; intraoperative imaging; medullary thyroid cancer; near infrared dye; pancreatic cancer; small cell lung cancer

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; FLUORESCENT DYE; LS 288; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; CRL-LS288; INDOLE DERIVATIVE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER SURGERY; CELL STRAIN HEK293; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; METASTASIS; MOUSE; MURINAE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC USE; DRUG DELIVERY SYSTEM; EVALUATION STUDY; HEK293 CELL LINE; HUMAN; INFRARED RADIATION; METABOLISM; NEOPLASMS; SYNTHESIS;

ANIMALS; BENZODIAZEPINONES; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HEK293 CELLS; HUMANS; INDOLES; INFRARED RAYS; MICE; MOLECULAR STRUCTURE; NEOPLASMS; PROTEIN BINDING; RECEPTOR, CHOLECYSTOKININ B;

EID: 84893318265     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400429h     Document Type: Article

References (78)

1. Aliperti, L. A.; Predina, J. D.; Vachani, A.; Singhal, S. Local and systemic recurrence is the Achilles heel of cancer surgery Ann. Surg. Oncol. 2011, 18, 603-607
2. Munkarah, A. R.; Hallum, A. V.; Morris, M.; Burke, T. W.; Levenback, C.; Atkinson, E. N.; Wharton, J. T.; Gershenson, D. M. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer Gynecol. Oncol. 1997, 64, 13-17 (Pubitemid 27026950)
3. Curtin, J. P.; Malik, R.; Venkatraman, E. S.; Barakat, R. R.; Hoskins, W. J. Stage IV ovarian cancer: impact of surgical debulking Gynecol. Oncol. 1997, 64, 9-12 (Pubitemid 27026949)
4. Changa, S.; Bristow, R. E. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining 'optimal' residual disease Gynecol. Oncol. 2012, 125, 483-492
5. Rapiti, E.; Verkooijen, H. M.; Vlastos, G.; Fioretta, G.; Neyroud-Caspar, I.; Sappino, A. P.; Chappuis, P. O.; Bouchardy, C. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis J. Clin. Oncol. 2006, 24, 2743-9 (Pubitemid 46630571)
6. Lacroix, M.; Abi-Said, D.; Fourney, D. R.; Gokaslan, Z. L.; Shi, W.; DeMonte, F.; Lang, F. F.; McCutcheon, I. E.; Hassenbusch, S. J.; Holland, E.; Hess, K.; Michael, C.; Miller, D.; Sawaya, R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J. Neurosurg. 2001, 95, 190-198 (Pubitemid 32799739)
7. Yamaguchi, S.; Kobayashi, H.; Terasaka, S.; Ishii, N.; Ikeda, J.; Kanno, H.; Nishihara, H.; Tanaka, S.; Houkin, K. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas Jpn. J. Clin. Oncol. 2012, 42, 270-277
8. Yuequan, J.; Zhi, Z.; Chenmin, X. Surgical Resection for Small Cell Lung Cancer: Pneumonectomy versus Lobectomy ISRN Surg. 2012, 101024
9. Badzioa, A.; Kurowskib, K.; Karnicka-Mlodkowska, H.; Jassema, J. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer Eur. J. Cardiothorac. Surg. 2004, 26, 183-188 (Pubitemid 38759944)
10. Karrer, K.; Ulsperger, E. Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group Acta Oncol. 1995, 34, 899-906
11. Veness, M. J.; Morgan, G. J.; Palme, C. E.; Gebski, V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice Laryngoscope 2005, 115, 870-5 (Pubitemid 40604696)
12. Khanfir, K.; Alzieu, L.; Terrier, P.; Le Péchoux, C.; Bonvalot, S.; Vanel, D.; Le Cesne, A. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities? Eur. J. Cancer 2003, 39, 1872-1880 (Pubitemid 37311183)
13. Flanigan, R. C.; Salmon, S. E.; Blumenstein, B. A.; Bearman, S. I.; Roy, V.; McGrath, P. C.; Caton, J. R., Jr.; Munshi, N.; Crawford, E. D. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N. Engl. J. Med. 2001, 345, 1655-1659 (Pubitemid 33126820)
14. Mickisch, G. H.; Garin, A.; van Poppel, H.; de Prijck, L.; Sylvester, R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 2001, 358, 966-970 (Pubitemid 32913522)
15. Carter, D. Margins of ″lumpectomy″ for breast cancer Hum. Pathol. 1986, 17, 330-332
16. Abraham, S. C.; Fox, K.; Fraker, D.; Solin, L.; Reynolds, C. Sampling of grossly benign breast reexcisions: a multidisciplinary approach to assessing adequacy Am. J. Surg. Pathol. 1999, 23, 316-22 (Pubitemid 29117568)
17. Madajewski, B.; Brendan, F. J.; Mouchli, A.; Kapoor, V.; Holt, D.; Wang, M. D.; Nie, S.; Singhal, S. Intraoperative Near-Infrared Imaging of Surgical Wounds after Tumor Resections Can Detect Residual Disease Clin. Cancer Res. 2012, 18, 5741-51
18. Themelis, G.; Harlaar, N. J.; Kelder, W.; Bart, J.; Sarantopoulos, A.; van Dam, G. M.; Ntziachristos, V. Enhancing Surgical Vision by Using Real-Time Imaging of avb3-Integrin Targeted Near-Infrared Fluorescent Agent Ann. Surg. Oncol. 2011, 18, 3506-3513
19. Pysz, M. A.; Gambhir, S. S.; Willmann, J. K. Molecular imaging: current status and emerging strategies Clin. Radiol. 2010, 65, 500-516
20. Frangioni, J. V. New technologies for human cancer imaging J. Clin. Oncol. 2008, 26, 4012-4021
21. Frangioni, J. V. In-Vivo Near Infrared Fluorescence Imaging Curr. Opin. Chem. Biol. 2003, 7, 626-34 (Pubitemid 37315800)
22. Hadjipanayis, C. G.; Jiang, H.; Roberts, D. W.; Yang, L. Current and Future Clinical Applications for Optical Imaging of Cancer: From Intraoperative Surgical Guidance to Cancer Screening Semin. Oncol. 2011, 38, 109-118
23. van Dam, G. M.; Themelis, G.; Crane, L. M. A.; Harlaar, N. J.; Pleijhuis, R. G.; Kelder, W.; Sarantopoulos, A.; de Jong, J. S.; Arts, H. J. G.; van der Zee, A. J. G.; Bart, J.; Low, P. S.; Ntziachristos, V. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-á targeting:first in-human results Nat. Med. 2011, 17, 1315-9
24. Gioux, S.; Choi, H. S.; Frangioni, J. V. Image-Guided Surgery using Invisible Near-Infrared Light:Fundamentals of Clinical Translation Mol. Imaging 2010, 9, 237-255
25. Ballou, B.; Fisher, G. W.; Hakala, T. R.; Farkas, D. L. Tumor Detection and Visualization Using Cyanine Fluorochrome-Labeled Antibodies Biotechnol. Prog. 1997, 13, 649-658 (Pubitemid 27442053)
26. Intes, X.; Ripoll, J.; Chen, Y.; Nioka, S.; Yodh, A. G.; Chance, B. In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green Med. Phys. 2003, 30, 1039-47 (Pubitemid 36735969)
27. Licha, K.; Riefke, B.; Ntziachristos, V.; Becker, A.; Chance, B.; Semmler, W. Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization Photochem. Photobiol. 2000, 72, 392-8
28. Stylianopoulos, T.; Jain, R. K. Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 2010, 7, 653-664
29. Cao, Y.; Yang, K.; Li, Z.; Zhao, C.; Shi, C.; Yang, J. Near-infrared quantum-dot-based non-invasive in vivo imaging of squamous cell carcinoma U14 Nanotechnology 2010, 21, 475104
30. Fu, A.; Wilson, R. J.; Smith, B. R.; Mullenix, J.; Earhart, C.; Akin, D.; Guccione, S.; Wang, S. X.; Gambhir, S. S. Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects ACS Nano 2012, 6, 6862-9
31. Hagtvet, E.; Evjen, T. J.; Nilssen, E. A.; Olsen, D. R. Assessment of liposome biodistribution by non-invasive optical imaging: a feasibility study in tumour-bearing mice J. Nanosci. Nanotechnol. 2012, 12, 2912-8
32. Maki, S.; Konno, T.; Maeda, H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium Cancer 1985, 56, 751-757 (Pubitemid 15228264)
33. Nagamitsu, A.; Greish, K.; Maeda, H. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors Jpn. J. Oncol. 2009, 39, 756-766
34. Heneweer, C.; Holland, J. P.; Divilov, V.; Carlin, S.; Lewis, J. S. Magnitude of enhanced permeablity and retention effect in tumors with different phenotypes: 89Zr-Albumin as a model system J. Nucl. Med. 2011, 52, 625-633
35. Li, J.; Chen, K.; Liu, H.; Cheng, K.; Yang, M.; Zhang, J.; Cheng, J. D.; Zhang, Y.; Cheng, Z. Activatable Near-Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha Bioconjugate Chem. 2012, 23, 1704-11
36. Urano, Y.; Sakabe, M.; Kosaka, N.; Ogawa, M.; Mitsunaga, M.; Asanuma, D.; Kamiya, M.; Young, M. R.; Nagano, T.; Choyke, P. L.; Kobayashi, H. Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe Sci. Transl. Med. 2011, 3, 110-119
37. Tung, C. H.; Bredow, S.; Mahmood, U.; Weissleder, R. Preparation of a cathepsin D sensitive nearinfrared fluorescence probe for imaging Bioconjugate Chem. 1999, 10, 892-896 (Pubitemid 29456379)
38. Nguyen, Q. T.; Olson, E. S.; Aguilera, T. A.; Jiang, T.; Scadeng, M.; Ellies, L. G.; Tsien, R. Y. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 4317-22
39. Lee, H.; Akers, W.; Bhushan, K.; Bloch, S.; Sudlow, G.; Tang, R.; Achilefu, S. Near-infrared pH-activatable fluorescent probes for imaging primary and metastatic breast tumors Bioconjugate Chem. 2011, 22, 777-84
40. Nakajima, T.; Mitsunaga, M.; Bander, N. H.; Heston, W. D.; Choyke, P. L.; Kobayashi, H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate Bioconjugate Chem. 2011, 22, 1700-5
41. Kohei, S.; Mitsunaga, M.; Nakajima, T.; Choyke, P. L.; Kobayashi, H. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores Breast Cancer Res. 2012, 14, R61
42. Kobayashi, H.; Choyke, P. L. Target-cancer cell specific activatable fluorescence imaging Probes: Rational Design and in vivo Applications Acc. Chem. Res. 2011, 44, 83-90
43. Yhee, J. Y.; Kim, S. A.; Koo, H.; Son, S.; Ryu, J. H.; Youn, I.; Choi, K.; Kwon, I. C.; Kim, K. Optical Imaging of Cancer-Related Proteases Using Near-Infrared Fluorescence Matrix Metalloproteinase-Sensitive and Cathepsin B-Sensitive Probes Theranostics 2012, 2, 179-189
44. Kobayashi, H.; Choyke, P. L. Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications Acc. Chem. Res. 2011, 44, 83-90
45. Kossatz, S.; Behe, M.; Mansi, R.; Saur, D.; Czerney, P.; Kaiser, W. A.; Ingrid, H. Multifactorial diagnostic NIR imaging of CCK2R expressing tumors Biomaterials 2013, 34, 5172-5180
46. Grötzinger; Becker, B.; Hessenius, C.; Licha, K.; Ebert, B.; Sukowski, U.; Semmler, W. Bertram Wiedenmann & Carsten. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nat. Biotechnol. 2001, 19, 327-331 (Pubitemid 32275340)
47. Becker, A.; Hessenius, C.; Licha, K.; Ebert, B.; Sukowski, U.; Semmler, W.; Wiedenmann, B.; Grötzinger, C. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nat. Biotechnol. 2001, 19, 327-331 (Pubitemid 32275340)
48. Kennedy, M. D.; Jallad, K. N.; Thompson, D. H.; Ben-Amotz, D.; Low, P. S. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe J. Biomed. Opt. 2003, 8, 636-641
49. Zielinski, R.; Hassan, M.; Lyakhov, I.; Needle, D.; Chernomordik, V.; Garcia-Glaessner, A.; Ardeshirpour, Y.; Capala, J.; Gandjbakhche, A. Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging PLoS One 2012, 7, e41016
50. Laabs, E.; Behe, M.; Kossatz, S.; Frank, W.; Kaiser, W. A.; Hilger, I. Optical imaging of CCK2/gastrin receptor-positive tumors with a minigastrin near-infrared probe Invest. Radiol. 2011, 46, 196-201
51. Licha, K.; Hessenius, C.; Becker, A.; Henklein, P.; Bauer, M.; Wisniewski, S.; Wiedenmann, B.; Semmler, W. Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes Bioconjugate Chem. 2001, 12, 44-50 (Pubitemid 32111452)
52. Low, P. S.; Kularatne, S. A. Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 2009, 13, 256-262
53. Little, T. J.; Horowitz, M.; Feinle-Bisset, C. Role of cholecystokinin in appetite control and body weight regulation Obes. Rev. 2005, 6, 297-306 (Pubitemid 41578599)
54. Bowers, M. E.; Choi, D. C.; Ressler, K. J. Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y Physiol. Behav. 2012, 107, 699-710
55. Walsh, J. H.; Dockray, O. J. Gut Peptides; Biochemistry and Physiology Raven Press: New York, 1994.
56. Mantyh, C. R.; Pappas, T. N.; Vigna, S. R. Localization ofcholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract Gastroenterology 1994, 107, 1019-1030
57. Dufresne, M.; Seva, C.; Fourmy, D. Cholecystokinin and Gastrin Receptors Physiol. Rev. 2006, 86, 805-847 (Pubitemid 44033383)
58. Ryberg, A.; Borch, K.; Monstein, H. J. Expression of multiple forms of 3′ end variant CCK2 receptor mRNA in human pancreatic adenocarcinomas BMS Res. Notes 2011, 4, 131
59. Reubi, J. C.; Waser, B. Unexpected high incidence of cholecystokinin B/gastrin receptors in human medullary thyroid carcinomas Int. J. Cancer 1996, 67, 644-647 (Pubitemid 26300980)
60. Sethi, T.; Herget, T.; Wu, S. V.; Walsh, J. H.; Rozengurt, E. CCK-A and CCK-B receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth Cancer Res. 1993, 53, 5208-5213 (Pubitemid 23333389)
61. Reubi, J. C.; Schaer, J. C.; Waser, B. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors Cancer Res. 1997, 57, 1377-86 (Pubitemid 27152565)
62. Hur, K.; Kwak, M. K.; Lee, H. J.; Park, D. J.; Lee, H. K.; Lee, H. S.; Kim, W. H.; Michaeli, D.; Yang, H. K. Expression of gastrin and its receptor in human gastric cancer tissues J. Cancer Res. Clin. Oncol. 2006, 132, 85-91 (Pubitemid 41752049)
63. Körner, M.; Waser, B.; Reubi, J. C.; Miller, L. J. CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours J. Cell Mol. Med. 2010, 14, 933-43
64. Kawasaki, D.; Emori, Y.; Eta, R.; Lino, Y.; Hamano, H.; Yoshinaga, K.; Tanaka, T.; Takei, M.; Watson, S. A. Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro Cancer Chemother. Pharmacol. 2008, 61, 883-892 (Pubitemid 351302043)
65. Grabowska, A. M.; Morris, T. M.; McKenzie, A. J.; Kumari, R.; Hamano, H.; Emori, Y.; Yoshinaga, K.; Watson, S. A. Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models Regul. Pept. 2008, 146, 46-57
66. Katsuo, S.; Murata, M.; Maeda, K.; Taguchi, H.; Kawase, N.; Miura, N. Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same. Patent US 6747022 B2, 2002.
67. Lauffer, D. J.; Mullican, M. D. A practical synthesis of (S) 3-tert-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-Mimetic for caspase-1 (ICE) inhibitors Bioorg. Med. Chem. Lett. 2002, 12, 1225-7 (Pubitemid 34270568)
68. Shinozaki, K.; Yoneta, T.; Murata, M.; Miura, N.; Maeda, K. 1,5-Benzodiazepine derivatives. U.S. Patent 6,344,452 BI, Feb 5, 2002.
69. Hyeran, L.; Mason, J. C.; Achilefu, S. Heptamethine Cyanine Dyes with a Robust C-C Bond at the Central Position of the Chromophore J. Org. Chem. 2006, 71, 7862-7865 (Pubitemid 44470332)
70. Smith, J. P.; Verderame, M. F.; McLaughlin, P.; Martenis, M.; Ballard, E.; Zagon, I. S. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer Int. J. Mol. Med. 2002, 10, 689-694
71. Olszewska-Pazdrak, B.; Townsend, C. M., Jr.; Hellmich, M. R. Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant J. Biol. Chem. 2004, 279, 40400-4 (Pubitemid 39287628)
72. Chao, C.; Goluszko, E.; Lee, Y. T.; Kolokoltsov, A. A.; Davey, R. A.; Uchida, T.; Townsend, C. M., Jr. Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1a expression and tumor growth Oncogene 2007, 26, 1013-1019
73. Reubi, J. C.; Körner, M.; Waser, B.; Mazzucchelli, L.; Guillou, L. High expression of peptide receptors as a novel target in gastrointestinal stromal tumours Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 803-810 (Pubitemid 38758349)
74. Monstein, H. J.; Nylander, A. G.; Salehi, A.; Chen, D.; Lundquist, I.; HaÌŠkanson, R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study Scand. J. Gastroenterol. 1996, 31, 383-90 (Pubitemid 26117760)
75. Maack, J.; Johnson, V.; Kan, T.; Figueiredo, J.; Sigulem, D. Renal filtration. transport and metabolism of low molecular weight proteins: A review Kidney Int. 1979, 16, 251-270 (Pubitemid 10208487)
76. Lei, X.; Begum, S.; Hearn, J. D.; Hynes, R. O. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanomatumor growth and metastasis Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 9023-9028 (Pubitemid 43902526)
77. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat. Rev. Cancer 2003, 3
78. Skotland, T. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use Contrast Media Mol. Imaging 2012, 7, 1-6